Currently, numerous reports have investigated Girdin’s regulatory role in various cancers, including liver cancer [10], non-small cell lung cancer [11], breast cancer [12], colorectal cancer [13], and esophageal cancer [14]. This evidence concerns the gene CCDC88A and cancer.